Alere, Inc. (ALR): Today's Most Compelling Stock Buy
|SoTM Bull's Eye Report - Today's Most Compelling Buy |
Tuesday, May 14, 2013
At StateoftheMarkets.com, we strive to "own the best and ignore the rest" in our equity portfolios. Toward this end, each day we search our database for a "top stock" (a top rated company in terms of earnings strength as well as company and industry performance) that presents a strong technical "set up" and a good entry point.
In short, when our equity team is looking to add a stock to one of our portfolios, the "bull's eye" stock shown below is generally their first choice.
|Alere Inc||ALR||Health Care Supplies||9.1||+40.34%||$25.41|
Why We Like The Stock:
Alere Inc (ALR) is our most compelling buy today due to the fact that it is a top- rated stock (in terms of earnings strength and company/industry performance) in our top rated sector, Health Care. While Biotech and Health Care Facilities stocks have been getting more of the attention lately, Health Care Supplies stocks have been having a sneaky good year so far. Cooper Cos (COO), Align Technology Inc (ALGN), West Pharma Services (WST), and Alere Inc (ALR) have all been straight up in 2013. Since crossing above its 50-day moving average back in early January, ALR has been operating well above it while maintaining a stellar interemediate-term uptrend. We like ALR because of the strength of this uptrend, the fact that it is nowhere near extended on a weekly basis, and also that it just broke through critical weekly resistance at $26.00 (see its struggles in Q1-Q2 of 2012). As long as it can maintain its price above the 50-day moving average, we like ALR to continue its march higher and would be buyers at current prices.
|We Would Be Buyers: |
At the current price (~$26.75).
Looking to trade the Bull's Eye stock picks? Click here to download our free Special Report, "How We Identify Our “Bull’s Eye” Picks & How You Can Profit Trading Them"
|Company Profile: |
Alere Inc. is engaged in developing capabilities in near-patient diagnosis, monitoring and health management. The Company’s products and services, as well as its new product development efforts, focuses on cardiology, infectious disease, toxicology, diabetes, oncology and women’s health. The Company operates in three segments: professional diagnostics, health management and consumer diagnostics. In December 2011, the Company acquired Method Factory, Inc (doing business as, Wellogic). On November 23, 2011, the Company acquired Arriva Medical LLC (Arriva). On November 1, 2011, it acquired Axis-Shield plc (Axis-Shield). In November 2011, it acquired 1 Medical Distribution, Inc. On October 3, 2011, it acquired Avee Laboratories Inc. In February 2013, it acquired Epocal, Inc.
Note: Positions may be bought or sold while this publication is in circulation without notice.
Alere Inc - Last 3 Months
Alere Inc - Last 12 Months
Alere Inc - Last 5 Years
The analysis and information in this report and on our website is for informational purposes only. No part of the material presented in this report or on our websites is intended as an investment recommendation or investment advice. Neither the information nor any opinion expressed nor any Portfolio constitutes a solicitation to purchase or sell securities or any investment program. The opinions and forecasts expressed are those of the editors of StateoftheMarkets.com and may not actually come to pass. The opinions and viewpoints regarding the future of the markets should not be construed as recommendations of any specific security nor specific investment advice. Stocks should always consult an investment professional before making any investment.
Any investment decisions must in all cases be made by the reader or by his or her investment adviser. Do NOT ever purchase any security without doing sufficient research. There is no guarantee that the investment objectives outlined will actually come to pass. All opinions expressed herein are subject to change without notice. Neither the editor, employees, nor any of their affiliates shall have any liability for any loss sustained by anyone who has relied on the information provided.
The analysis provided is based on both technical and fundamental research and is provided 'as is' without warranty of any kind, either expressed or implied. Although the information contained is derived from sources which are believed to be reliable, they cannot be guaranteed.
The information contained in our websites and StateoftheMarkets.com publications is provided by Ridge Publishing Co. Inc. (Ridge). One of the principals of Ridge, Mr. David Moenning, is also President and majority shareholder of Heritage Capital Management, Inc. (HCM) a Chicago-based money management firm. HCM is registered as an investment adviser. HCM also serves as a sub-advisor to other investment advisory firms. Ridge is a publisher and has not registered as an investment adviser. Neither HCM nor Ridge is registered as a broker-dealer.
Employees and affiliates of HCM and Ridge may at times have positions in the securities referred to and may make purchases or sales of these securities while publications are in circulation. Editors will indicate whether they or HCM has a position in stocks or other securities mentioned in any publication. The disclosures will be accurate as of the time of publication and may change thereafter without notice.
Index returns are price only and do not include the reinvestment of dividends. The S&P 500 is a stock market index containing the stocks of 500 large-cap corporations, most of which are US companies. The index is the most notable of the many indices owned and maintained by Standard & Poor's, a division of McGraw-Hill. S&P 500 is used in reference not only to the index but also to the 500 companies that have their common stock included in the index.
Investments in equities carry an inherent element of risk including the potential for significant loss of principal. Past performance is not an indication of future results.